Though iPS cells have been developed during the last year or more at U-M, this is the first time the consortium has consistently sustained and coaxed the iPS cells into different cell types — a leap forward as the state positions itself in the growing field of biotechnology and stem cell research.
Three of the first five lines were derived from donors with bipolar disorder. Those lines will be used to study the condition.
FULL STORY
MORE INFORMATION ABOUT STEM CELL RESEARCH